Tackling challenges of TB/MDRTB in China: concerted actions are imperative

摘要

China is the second largest TB epidemic with the most number of people infected with multi-drug resistant (MDR). Over the past decade, a large number of TB control projects have been funded by the government of China and international organizations, and epidemic in China has been effectively controlled. However TB control in China still faced many challenges. Strategies to address these challenges may include integrating the national TB control program into health insurance schemes, strengthening TB case management through involving the Chinese hospital in national TB control program, and reforming payment methods for TB care as part of health system reform in China.Electronic supplementary materialThe online version of this article (doi:10.1186/s40249-015-0050-4) contains supplementary material, which is available to authorized users.